Clinical Trial

Belgian Registry on Coronary Function Testing

Study acronym: BELmicro
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 18, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this prospective, multicenter registy is to describe the 'real-world' use of coronary function tests, which may consist of bolus thermodilution measurements of coronary microvascular function and/or invasive vasoreactivity tests with acetylcholine, in the current Belgian routine practice. The main questions it aims to answer are: * how frequent are coronary function tests performed * what is the indication for coronary function tests * what is the frequency of coronary microvascular dysfunction * what is the frequency of coronary artery vasospasm From each participant, data will be collected from their medical files concerning cardiovascular risk factors, relevant past medical history, non-invasive tests, procedural data, and follow-up data from routine in-patient visits. Their are no specific study visits. Optionally, patients will be asked to fill in questionnaires about anginal symptoms and quality of life.
Trial Details
NCT Number NCT06089031
Lead Sponsor University Hospital, Antwerp
Conditions Coronary Microvascular Dysfunction, Coronary Artery Vasospasm
Enrollment 650 participants
Start Date 2021-10-18
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-10-18